BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 26780610)

  • 1. DNA methylation dynamics during B cell maturation underlie a continuum of disease phenotypes in chronic lymphocytic leukemia.
    Oakes CC; Seifert M; Assenov Y; Gu L; Przekopowitz M; Ruppert AS; Wang Q; Imbusch CD; Serva A; Koser SD; Brocks D; Lipka DB; Bogatyrova O; Weichenhan D; Brors B; Rassenti L; Kipps TJ; Mertens D; Zapatka M; Lichter P; Döhner H; Küppers R; Zenz T; Stilgenbauer S; Byrd JC; Plass C
    Nat Genet; 2016 Mar; 48(3):253-64. PubMed ID: 26780610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic and genetic alterations and their influence on gene regulation in chronic lymphocytic leukemia.
    Huang D; Ovcharenko I
    BMC Genomics; 2017 Mar; 18(1):236. PubMed ID: 28302063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Locally disordered methylation forms the basis of intratumor methylome variation in chronic lymphocytic leukemia.
    Landau DA; Clement K; Ziller MJ; Boyle P; Fan J; Gu H; Stevenson K; Sougnez C; Wang L; Li S; Kotliar D; Zhang W; Ghandi M; Garraway L; Fernandes SM; Livak KJ; Gabriel S; Gnirke A; Lander ES; Brown JR; Neuberg D; Kharchenko PV; Hacohen N; Getz G; Meissner A; Wu CJ
    Cancer Cell; 2014 Dec; 26(6):813-825. PubMed ID: 25490447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression analysis of the epigenetic methyltransferases and methyl-CpG binding protein families in the normal B-cell and B-cell chronic lymphocytic leukemia (CLL).
    Kn H; Bassal S; Tikellis C; El-Osta A
    Cancer Biol Ther; 2004 Oct; 3(10):989-94. PubMed ID: 15467427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide DNA methylation analysis reveals novel epigenetic changes in chronic lymphocytic leukemia.
    Pei L; Choi JH; Liu J; Lee EJ; McCarthy B; Wilson JM; Speir E; Awan F; Tae H; Arthur G; Schnabel JL; Taylor KH; Wang X; Xu D; Ding HF; Munn DH; Caldwell C; Shi H
    Epigenetics; 2012 Jun; 7(6):567-78. PubMed ID: 22534504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenomic analysis detects widespread gene-body DNA hypomethylation in chronic lymphocytic leukemia.
    Kulis M; Heath S; Bibikova M; Queirós AC; Navarro A; Clot G; Martínez-Trillos A; Castellano G; Brun-Heath I; Pinyol M; Barberán-Soler S; Papasaikas P; Jares P; Beà S; Rico D; Ecker S; Rubio M; Royo R; Ho V; Klotzle B; Hernández L; Conde L; López-Guerra M; Colomer D; Villamor N; Aymerich M; Rozman M; Bayes M; Gut M; Gelpí JL; Orozco M; Fan JB; Quesada V; Puente XS; Pisano DG; Valencia A; López-Guillermo A; Gut I; López-Otín C; Campo E; Martín-Subero JI
    Nat Genet; 2012 Nov; 44(11):1236-42. PubMed ID: 23064414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylation and silencing of protein tyrosine phosphatase receptor type O in chronic lymphocytic leukemia.
    Motiwala T; Majumder S; Kutay H; Smith DS; Neuberg DS; Lucas DM; Byrd JC; Grever M; Jacob ST
    Clin Cancer Res; 2007 Jun; 13(11):3174-81. PubMed ID: 17545520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deregulation of Aiolos expression in chronic lymphocytic leukemia is associated with epigenetic modifications.
    Billot K; Soeur J; Chereau F; Arrouss I; Merle-Béral H; Huang ME; Mazier D; Baud V; Rebollo A
    Blood; 2011 Feb; 117(6):1917-27. PubMed ID: 21139082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic and epigenetic profiling of CLL disease progression reveals limited somatic evolution and suggests a relationship to memory-cell development.
    Smith EN; Ghia EM; DeBoever CM; Rassenti LZ; Jepsen K; Yoon KA; Matsui H; Rozenzhak S; Alakus H; Shepard PJ; Dai Y; Khosroheidari M; Bina M; Gunderson KL; Messer K; Muthuswamy L; Hudson TJ; Harismendy O; Barrett CL; Jamieson CH; Carson DA; Kipps TJ; Frazer KA
    Blood Cancer J; 2015 Apr; 5(4):e303. PubMed ID: 25860294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TWIST2 demonstrates differential methylation in immunoglobulin variable heavy chain mutated and unmutated chronic lymphocytic leukemia.
    Raval A; Lucas DM; Matkovic JJ; Bennett KL; Liyanarachchi S; Young DC; Rassenti L; Kipps TJ; Grever MR; Byrd JC; Plass C
    J Clin Oncol; 2005 Jun; 23(17):3877-85. PubMed ID: 15809452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic deregulation in chronic lymphocytic leukemia: Clinical and biological impact.
    Mansouri L; Wierzbinska JA; Plass C; Rosenquist R
    Semin Cancer Biol; 2018 Aug; 51():1-11. PubMed ID: 29427646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mantle cell lymphoma displays a homogenous methylation profile: a comparative analysis with chronic lymphocytic leukemia.
    Halldórsdóttir AM; Kanduri M; Marincevic M; Mansouri L; Isaksson A; Göransson H; Axelsson T; Agarwal P; Jernberg-Wiklund H; Stamatopoulos K; Sander B; Ehrencrona H; Rosenquist R
    Am J Hematol; 2012 Apr; 87(4):361-7. PubMed ID: 22374828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic profiling in chronic lymphocytic leukemia reveals novel methylation targets.
    Rush LJ; Raval A; Funchain P; Johnson AJ; Smith L; Lucas DM; Bembea M; Liu TH; Heerema NA; Rassenti L; Liyanarachchi S; Davuluri R; Byrd JC; Plass C
    Cancer Res; 2004 Apr; 64(7):2424-33. PubMed ID: 15059895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extensive promoter DNA hypermethylation and hypomethylation is associated with aberrant microRNA expression in chronic lymphocytic leukemia.
    Baer C; Claus R; Frenzel LP; Zucknick M; Park YJ; Gu L; Weichenhan D; Fischer M; Pallasch CP; Herpel E; Rehli M; Byrd JC; Wendtner CM; Plass C
    Cancer Res; 2012 Aug; 72(15):3775-85. PubMed ID: 22710432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic dysregulation of the Wnt signalling pathway in chronic lymphocytic leukaemia.
    Chim CS; Pang R; Liang R
    J Clin Pathol; 2008 Nov; 61(11):1214-9. PubMed ID: 18765431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic profile in chronic lymphocytic leukemia using methylation-specific multiplex ligation-dependent probe amplification.
    Cosialls AM; Santidrián AF; Coll-Mulet L; Iglesias-Serret D; González-Gironès DM; Pérez-Perarnau A; Rubio-Patiño C; González-Barca E; Alonso E; Pons G; Gil J
    Epigenomics; 2012 Oct; 4(5):491-501. PubMed ID: 23130831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylome-based cell-of-origin modeling (Methyl-COOM) identifies aberrant expression of immune regulatory molecules in CLL.
    Wierzbinska JA; Toth R; Ishaque N; Rippe K; Mallm JP; Klett LC; Mertens D; Zenz T; Hielscher T; Seifert M; Küppers R; Assenov Y; Lutsik P; Stilgenbauer S; Roessner PM; Seiffert M; Byrd J; Oakes CC; Plass C; Lipka DB
    Genome Med; 2020 Mar; 12(1):29. PubMed ID: 32188505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uncovering the DNA methylome in chronic lymphocytic leukemia.
    Cahill N; Rosenquist R
    Epigenetics; 2013 Feb; 8(2):138-48. PubMed ID: 23321535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of novel epigenetic markers in non-Hodgkin's lymphoma.
    Shi H; Guo J; Duff DJ; Rahmatpanah F; Chitima-Matsiga R; Al-Kuhlani M; Taylor KH; Sjahputera O; Andreski M; Wooldridge JE; Caldwell CW
    Carcinogenesis; 2007 Jan; 28(1):60-70. PubMed ID: 16774933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene methylation in gastric cancer.
    Qu Y; Dang S; Hou P
    Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.